Details for 2012153939

Up to date per 02.04.2026

Actions

Title / Product Name

Pharmazeutische Formulierungen mit Dapagliflozin-Propylenglycol-Hydrat

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2012153939

EP Publication Number

2508188

E-Number

1566053

Language

PCT Number

Publication Date

10.10.2012 A

10.05.2023 B1

Registration Date

10.05.2023

AT Publication Date

15.05.2023

Application Date

21.03.2008

Registration Number

Priorities

22.03.2007

896286 P

IPC

A61K 31/70 20060101AFI20120903BHEP

Maximum Duration of Protection

21.03.2028

Owner

AstraZeneca AB 151 85 SödertäljeSE

Representative

Häupl & Ellmeyer KG, PatentanwaltskanzleiMariahilfer Straße 50 (Kirchengasse 1)1070 WienAT

Inventor

Bindra, Dilbir1 Squibb Drive New Brunswick, NJ 08903US

Dali, Mandar V.339 Tammy Lane Bridgewater, New Jersey 08807US

Parab, Prakash V.1 Squibb Drive New Brunswick, NJ 08903US

Patel, Jatin M.1 Squibb Drive New Brunswick, NJ 08903US

Tao, Li1 Squibb Drive New Brunswick, NJ 08903US

Tejwani, Ravindra W.1 Squibb Drive New Brunswick, NJ 08903US

Vatsaraj, Nipa1 Squibb Drive New Brunswick, NJ 08903US

Wu, Yongmei1 Squibb Drive New Brunswick, NJ 08903US

Information about Fees